Hypopigmented Lesions

Published on 25/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1369 times

Chapter 645 Hypopigmented Lesions

Albinism

Several types of congenital oculocutaneous albinism (OCA) consist of partial or complete failure of melanin production in the skin, hair, and eyes despite the presence of normal number, structure, and distribution of melanocytes. They may be divided into two major classes: those with abnormal protein function involved in the formation and transfer of melanin, and those with defects in melanosomes (Table 645-1). Tyrosinase is the copper-containing enzyme that catalyzes at multiple steps in melanin biosynthesis (Chapter 79.2). Tyrosinase-positive variants are characterized by darkening of the hair bulb on incubation with tyrosine.

Table 645-1 GENES ASSOCIATED WITH HYPOPIGMENTATION

DISORDER GENE DEFECT
Oculocutaneous albinism:
OCA1 Tyrosinase
OCA2 P protein
OCA3 TRP-1
OCA4 MATP
Hermansky-Pudlak:
Type 1 HPS-1 Mouse (pale ear)
Type 2 HPS-2 b3A subunit of AP3
Type 3 HPS-3 Mouse (cocoa)
Type 4 HPS-4 Mouse (light ear)
Type 5 HPS-5 KIAA107
Type 6 HPS-6 Mouse (ruby eye)
Type 7 HPS-7 DTNBP1
Type 8 HPS-8 Bloc153
Chédiak-Higashi CHS1/LYST
Piebaldism C-KIT receptor
Heterozygous SLUG
Waardenburg:
Type 1 Heterozygous PAX-3
Type 2a MITF
Type 2b Chromosome 1p
Type 2c Chromosome 8p23
Type 2d SNAIL
Type 2e Sox 10
Type 3 Homozygous PAX-3
Type 4 SOX 10
Endothelin 3
Endothelin B receptor

Oculocutaneous albinism type 1 (OCA1) is characterized by great reduction in or absence of tyrosinase activity. OCA1A, the most severe form, is characterized by a lack of visible pigment in hair, skin, and eyes (Fig. 645-1). This manifests as photophobia, nystagmus, defective visual acuity, white hair, and white skin. The irises are blue-gray in oblique light and prominent pink in reflected light. OCA1B, or yellow mutant albinism, manifests at birth as white hair, pink skin, and gray eyes. This type is particularly prevalent in Amish communities. Progressively the hair becomes yellow-red, the skin tans lightly on exposure to the sun, and the irises may accumulate some brown pigment, with a resultant improvement in visual acuity. Photophobia and nystagmus are present but mild. OCATS is a temperature-sensitive type of albinism. The abnormal tyrosinase has decreased activity at 35-37°C. Therefore, cooler regions of the body such as the limbs and head pigment to some degree, whereas other areas remain depigmented.

OCA2 ranges from nearly normal to closely resembling type 1 albinism. This is the most common form of albinism seen worldwide. Little or no melanin is present at birth, but pigment, particularly red-yellow pigment, may accumulate during childhood to produce straw-colored or light brown skin in white individuals. Pigmented nevi may develop. Progressive improvement in visual acuity and nystagmus occurs with aging. Black individuals may have yellow-brown skin, dark-brown freckles in sun-exposed areas, and brown coloration of the irises. Brown OCA is an allelic variant of OCA2. Prader-Willi and Angelman syndromes, which include hypopigmentation, have deletions that include the gene involved in OCA2.

OCA3 (rufous albinism) is seen predominantly in patients of African descent. It is characterized by red hair, reddish brown skin, pigmented nevi, freckles, reddish brown to brown eyes, nystagmus, photophobia, and decreased visual acuity.

OCA4 is a rare OCA with clinical findings similar to those in OCA2.

The Cross-McKusick-Breen syndrome consists of tyrosinase-positive albinism with ocular abnormalities, retardation, spasticity, and athetosis. The genetic defect is unidentified.

Because of the absence of normal protection by adequate amounts of epidermal melanin, persons with albinism are predisposed to development of actinic keratoses and cutaneous carcinoma secondary to skin damage by ultraviolet light. Protective clothing and a broad-spectrum sunscreen preparation (Chapter 648) should be worn during exposure to sunlight.

Oculocutaneous Albinism with Melanosomal Abnormalities (See Table 645-1)

Hermansky-Pudlak syndrome is a collection of autosomal recessive genetic disorders characterized by oculocutaneous albinism, ceroid accumulation in lysosomes, and prolonged bleeding time. In mice, 16 distinct genetic loci that produce coat color mutant phenotypes associated with platelet deficiencies are recognized; eight have been identified in humans.

Chédiak-Higashi syndrome (CHS; Chapter 124) is another genetic abnormality associated with dysfunction of lysosome-related organelles. Patients with CHS have hypopigmentation of the skin, eyes, and hair; prolonged bleeding times and easy bruising; recurrent infections; abnormal natural killer cell function; and peripheral neuropathy. CHS is caused by mutations in the CHS1/LYST gene, which is a lysosomal trafficking regulatory gene.

Melanoblast Migration Abnormalities (See Table 645-1)

Piebaldism

A congenital autosomal dominant disorder, piebaldism is characterized by sharply demarcated amelanotic patches that occur most frequently on the forehead, anterior scalp (producing a white forelock), ventral trunk, elbows, and knees. Islands of normal or darker than normal pigmentation may be present within the amelanotic areas (Fig. 645-2). The plaques are a result of a permanent localized absence of melanocytes. The pattern of depigmentation arises from defective melanoblast migration from the neural crest during development. The reason that piebaldism is a localized and not a generalized process remains unknown. Piebaldism must be differentiated from vitiligo, which may be progressive and is not usually congenital, nevus depigmentosus, and Waardenburg syndrome.

Hypomelanosis of Ito

Hypomelanosis of Ito is a congenital skin disorder affecting children of both sexes and frequently associated with defects in several organ systems. There is no evidence for genetic transmission; chromosomal mosaicism and chromosomal translocations have been reported. Hypomelanosis of Ito is currently a descriptive rather than definitive diagnosis. Blaschkoid hypomelanosis is a better descriptive term.

The skin lesions of hypomelanosis of Ito are generally present at birth but may be acquired in the first 2 years of life. The lesions are similar to a negative image of those present in incontinentia pigmenti, consisting of bizarre, patterned, hypopigmented macules arranged over the body surface in sharply demarcated whorls, streaks, and patches that follow the lines of Blaschko (Fig. 645-3). The palms, soles, and mucous membranes are spared. The hypopigmentation remains unchanged throughout childhood but fades during adulthood. The degree of depigmentation varies from hypopigmented to achromic. Neither inflammatory nor vesicular lesions precede the development of the pigmentary changes as in incontinentia pigmenti. The hypopigmented areas demonstrate fewer and smaller melanocytes and a decreased number of melanin granules in the basal cell layer than normal. Inflammatory cells and pigment incontinence are lacking.

The most commonly associated abnormalities involve the nervous system, including mental retardation (70%), seizures (40%), microcephaly (25%), and muscular hypotonia (15%). The musculoskeletal system is the second most frequently involved system, affected by scoliosis and thoracic and limb deformities. Minor ophthalmologic defects (strabismus, nystagmus) are present in 25% of patients, and 10% have cardiac defects. These frequencies are likely to be overestimated because patients with isolated skin disease often do not seek further evaluation. The differential diagnosis includes systematized nevus depigmentosus, which is a stable leukoderma not associated with systemic manifestations. Differentiation from incontinentia pigmenti, particularly the hypopigmented fourth stage, is critical for genetic counseling because incontinentia pigmenti, unlike hypomelanosis of Ito, is inherited.

Vitiligo

Epidemiology and Etiology

Vitiligo is macular depigmentation associated with the destruction of melanocytes. The disorder represents a clinical end-point resulting from a complex interaction of environmental, genetic, and immunologic factors. Autoimmune, genetic, autocytotoxic, and neural theories have been postulated. The prevalence is 0.5% of most populations.

There is definitely an autoimmune component to vitiligo. Eighty percent of patients with active disease have an antibody to a surface antigen on pigmented melanoma cells. These antibodies appear to be cytotoxic for melanocytes. There is also a correlation between disease activity and the titer of serum antimelanocyte antibody. Melanocyte-specific CD8+ T lymphocytes are also involved in the pathogenesis of vitiligo. These antibodies and T cells recognize a variety of melanocyte enzymatic and structural proteins.

The genetic epidemiology of vitiligo is part of a broader genetically determined autoimmune and autoinflammatory diathesis. Fifteen percent to 20% of patients with generalized vitiligo have one or more affected first-degree relatives. In these families the genetic pattern is suggestive of polygenic, multifactorial inheritance. In the other patients, the disease occurs sporadically.

Many authorities believe that the cause of melanocyte destruction in vitiligo is an endogenous cellular abnormality. It has been suggested that melanocytes are destroyed because of the accumulation of a toxic melanin synthesis intermediate and/or lack of protection from hydrogen peroxide and other oxygen radicals. There is in vitro evidence that some of these metabolites may be lethal to melanocytes. Others believe that neurochemical factors damage melanocytes and cause depigmentation. This possibility would explain the pattern of involvement in segmental vitiligo that runs roughly along the course of a dermatome.

Clinical Manifestations

There are two subtypes of vitiligo, generalized (nonsegmental) and segmental, which probably are distinctly different diseases (Table 645-2). Generalized vitiligo (85-90% of cases) may be divided into widespread (type A) and localized (type B). About 50% of all patients with vitiligo have onset before 18 yr of age, and 25% demonstrate depigmentation before age 8. Most children have the generalized form, but the segmental type is more common among children than among adults. Patients with the generalized form usually present with a remarkably symmetric pattern of white macules and patches (Fig. 645-4); the margins may be somewhat hyperpigmented. The patches tend to be acral and/or periorificial. Occasionally, almost the entire skin surface becomes depigmented.

Table 645-2 TYPICAL FEATURES OF SEGMENTAL AND NONSEGMENTAL VITILIGO

SEGMENTAL VITILIGO NONSEGMENTAL VITILIGO
Often begins in childhood Can begin in childhood, but later onset is more common
Has rapid onset and stabilizes Is progressive, with flare-ups
Involves hair compartment soon after onset Involves hair compartment in later stages
Is usually not accompanied by other autoimmune diseases Is often associated with personal or family history of auto-immunity
Often occurs in the face Commonly occurs at sites sensitive to pressure and friction and prone to trauma
Is usually responsive to autologous grafting, with stable repigmentation Frequently relapses in situ after autologous grafting
Can be difficult to distinguish from nevus depigmentosus, especially in cases with early onset  

From Taïeb A, Picardo M: Vitiligo, N Engl J Med 360:160–168, 2009.

There are several varieties of localized vitiligo. A form of localized vitiligo is the halo nevus phenomenon, whereby benign moles develop depigmented rings at the periphery. Premature graying of scalp hair (canities) has also been considered a form of localized vitiligo. In segmental vitiligo, depigmented areas are limited to a quasidermatomal distribution. This type of vitiligo has a rapid onset and progression in a localized area without the development of depigmentation in other areas.

A number of autoimmune diseases occur in patients with vitiligo, including Addison disease, Hashimoto thyroiditis, pernicious anemia, diabetes mellitus, hypoparathyroidism, and polyglandular autoimmune syndrome with selective immunoglobulin (Ig) A deficiency. In addition, other diseases with possible immune defects, such as alopecia areata and morphea, have been seen in patients with vitiligo.

Vogt-Koyanagi-Harada syndrome is vitiligo associated with uveitis, dysacusia, meningoencephalitis, and depigmentation of the skin, scalp hair, eyebrows, and eyelashes. In the Alezzandrini syndrome, vitiligo is associated with tapetoretinal degeneration and deafness.

Light microscopic examination of early lesions shows mild inflammatory change. Over time, degenerative changes occur in melanocytes, leading to their complete disappearance.

The differential diagnosis of vitiligo includes other causes of widespread acquired leukoderma. The two most common problem diagnoses are tinea versicolor and postinflammatory hypopigmentation.